Fig. 1 · Structure
Documents & Downloads
Gemcitabine monophosphate disodium
Gemcitabine Intermediate
Gemcitabine monophosphate disodium is an active intermediate of the nucleoside analog gemcitabine. This compound exhibits synergistic anti-cancer activity and can enhance therapeutic efficacy when delivered via nanoparticle formulation. Its relevance in cancer research is underscored by its potential for improving drug delivery systems and treatment outcomes in various malignancies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1638288-31-9 |
| Applications | Gemcitabine Intermediate |
| Formula | C9H10F2N3Na2O7P |
| Molecular Weight | 387.14 |
| Synonyms | Gemcitabine 5′-phosphate disodium |
| SMILES | O=P(O[Na])(O[Na])OC[C@@H]1[C@@H](O)C(F)(F)[C@H](N2C=CC(N)=NC2=O)O1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.